Irbesartan + Hidroclorotiazida Gp (Hydrochlorothiazide, Irbesartan)

Irbesartan/Hydrochlorothiazide acts on the renin‑angiotensin system and renal sodium handling to control elevated blood pressure.

• Hypertension: reduces systolic and diastolic pressure in patients with primary hypertension.
• Essential hypertension: improves blood‑pressure control when monotherapy is insufficient.
• High blood pressure with fluid retention: combines vasodilation and diuresis for better overall control.

• Irbesartan blocks angiotensin II binding to AT1 receptors, causing vasodilation and decreasing aldosterone release. Hydrochlorothiazide inhibits Na⁺/Cl⁻ reabsorption in the distal convoluted tubule, increasing urinary sodium and water excretion, which lowers plasma volume and further reduces blood pressure.

The combination may cause several adverse reactions, ranging from mild to severe.

Common Side Effects

• Dizziness: feeling light‑headed, especially after standing.
• Headache: mild to moderate pain in the head region.
• Fatigue: unusual tiredness or lack of energy.
• Increased urination: more frequent need to void.
• Electrolyte imbalance (low potassium): may cause muscle cramps.
• Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

• Severe dehydration: marked fluid loss requiring medical attention.
• Acute kidney injury: sudden decline in renal function.
• Allergic reactions: rash, itching, or hives.
• Angioedema: swelling of face, lips, or throat.
• Severe hypotension: dangerously low blood pressure.
• Blood dyscrasias: rare blood cell abnormalities.

Patients should be aware of specific safety considerations before using this medication.

• Monitor blood pressure: ensure therapeutic targets are reached without excessive lowering.
• Assess renal function: check creatinine and eGFR periodically.
• Check electrolytes: especially potassium and sodium levels.
• Avoid use in pregnancy: category D, risk to the fetus.
• Use caution in elderly: increased sensitivity to blood‑pressure changes.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Irbesartan/Hydrochlorothiazide can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

• Aliskiren (in diabetic patients): may increase risk of renal impairment.
• Potassium‑sparing diuretics: can cause dangerous hyper‑kalemia.
• NSAIDs: may blunt antihypertensive effect and affect kidney function.

Moderate Interactions (Monitor Closely)

• Lithium: increased lithium levels may lead to toxicity.
• ACE inhibitors or other ARBs: combined use raises hyper‑kalemia risk.